Normal erythrocyte calpain I activity on membrane proteins under near-physiological conditions in patients with essential hypertension
Keywords:
Calpain I, Calpastatin, Red cell membrane proteins, Band2.1, Band4.1, Essential hypertensionAbstract
CONTEXT: It has been reported that the equilibrium between the erythrocyte protease calpain I and its physiological inhibitor calpastatin is disrupted in patients with essential hypertension. OBJECTIVE: To investigate the activity of non-purified calpain I in hemolysates against the erythrocytic membrane proteins, rather than against other substrates. DESIGN: Evaluation of calpain I red cell activity upon its own physiological substrates in hypertensive patients, in a near-physiological environment. SETTING: LIM-23 and LIM-40 of Hospital das Clinicas of the Faculty of Medicine of USP. SAMPLE: Patients with moderate primary hypertension over 21 years of age who were given amlodipine (n:10) and captopril (n:10) for 8 weeks, plus normal controls (n:10). MAIN MEASUREMENTS: Red cell membrane proteins were incubated with and with out protease inhibitors and with and without calcium chloride and under went polyacrylamidegelel ectrophoresis. RESULTS: Digestion of bands 2.1 and 4.1 was observed, indicating calpain I acitivity. No statistical differences regarding bands 2.1 and 4.1 were observed before treatment, between the controls and the hypertensive patients, either in ghosts prepared with out calcium or with increasing concentrations of calcium. Nor were statistical differences observed after treatment, betweenthe controls and the patients treated with amlodipine and captopril, or between the patients before and after treatment with bothdrugs. CONCLUSION: The final activity of non-purified calpain I upon its own physiological substrate, which was the approach utilized in this study,may more adequately reflect what happensin red cells. Under such conditions no imbalance favoring calpain I activity increase was observed. The protective factor provided by calpastatin against calpainI activity may diminis hunder hypertension.
Downloads
References
Editorial. Genetics, environment and hypertension. Lancet 1985;I:681-2.
Garay RP, Meyer P. A new test showing abnormal net Na and K influx in erythrocytes of essential hypertensive patients. Lancet 1979;1(8112):349-53.
Canessa M, Adragna N, Solomon H, Connolly TM, Tosteson DC. Increased Na-Li counter-transport in red cells of patients with essential hypertension. N Engl J Med 1980;302:772-8.
Garay RP, Dagher G, Pernollet MG, Devynck MA, Meyer P. Inherited defect in a (Na-K) counter-transport in erythrocytes from essential hypertensive patients. Nature 1980;284:281-3.
Fleckenstein A, Frei M, Zorn J, Fleckenstein-Grun G. The role of calcium in the pathogenesis of experimental arteriosclerosis. Trends Pharmacol Sci 1987;8:496-501.
Postnov V, Orlov SN, Gulak PV, Shevchenko AS. Evidence of altered permeability of the erythrocyte membrane for sodium and potassium ions in spontaneous hypertensive rats. Clin Sci Mol Med 1976;51(suppl 3):169-72.
Bianchi G, Ferrari P, Trizio D, Ferrandi M, Torielli L, Barber BR, Poli E. Red blood cell abnormalities and spontaneous hypertension in rat. Hypertension (Dallas) 1985;7:319-25
Pontremoli S, Melloni E, Sparatore B, et al. Erythrocyte deficiency in calpain inhibitor activity in essential hypertension. Hypertension 1988;12:474-8.
Pontremoli S, Salamino F, Sparatore B, De Tullio R, Pontremoli R, Melloni E. Characterization of the calpastatin defect in erythrocytes from patients with essential hypertension. Biochem Biophys Res Comm 1988;157:867-74.
Salamino F, Sparatore B, de Tullio R, Pontremoli R, Melloni E, Pontremoli S. The calpastatin defect in hypertension is possibly due to a specific degradation by calpain. Biochim Biophys Acta 1991;1096:265-9.
Pontremoli S, Melloni E, Sparatore B, Salamino F, Michetti M, Sacco O, Horecker BL. Binding to erythrocyte membrane is the physiological mechanism for activation of Ca2+-dependent neutral proteinase. Biochem Biophys Res Comm 1985;128:331-8.
Kuboki M, Ishi H, Kazawa M. Characterization of calpain I binding proteins in human erythrocyte plasma membrane. J Biochem (Tokyo) 1990;107:776-80.
Melloni E, Salamino F, Sparatore B, Michetti M, Pontremoli S. Ca2+-dependent neutral proteinase from human erythrocytes: activation by Ca2+ ions and substrate and regulation by the endogenous inhibitor. Biochem Int 1984;477-89.
The 1988 Report of the National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1988;148:1023-38.
Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 1963;100:119-30.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
Fairbanks G, Steck TL, Wallach DFH. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 1971;10:2606-17.
David-DuFilho M, Astarie C, Pernollet M, Del Pino M, Levenson J, Simon A, Devinck M. Control of the erythrocyte- free Ca2+ concentration in essential hypertension. Hypertension 1992;19:167-74.
Touyz RM, Milne FJ, Reinach SG. Intracellular Mg2+, Ca2+, Na+ and K+ in platelets and erythrocytes of essential hypertension patients: relation to blood pressure. Clin Exp Hypert A 1992;14:1189-209.
Pontremoli S, Melloni E, Salamino F, et al. Decreased level of calpain inhibitor activity in kidney from Milan hypertensive rats. Biochem Biophys Res Comm 1987;145:1287-94
